New Formula of StemStrength by AngioSoma Inc. Now Available to The Public Online

HOUSTON, TX, Oct. 15, 2018 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE – AngioSoma (SOAN), a leading biotechnology company, announces today the availability of the anticipated new and improved version of its popular StemStrength™ formula. The new StemStrength™ is available for both women and men, plus it will come in an AM and PM formulation. The new product will be offered through AngioSoma’s retail brand, SomaCeuticals (

StemStrength™ is a natural nutraceutical, delivered in capsule form, engineered to provide energy, focus, accelerated fat loss, and more rapid muscle gain, among many other benefits.  Designed to be taken in the morning and before bed for maximum effect, StemStrength™ represents a complete solution for Women and Men looking for an edge in their workouts or daily life.   The timing of supplementation is important since the body needs different nutrients in the morning than in the evening. The morning formula excels at creating energy, focus and power for the day’s work ahead. The evening formula maximizes your recovery and helps you enjoy a restful sleep.

The new StemStrength™ is now available for purchase in the company’s ecommerce store   “We are excited to bring this new formulation to market through our store online.” said Alex Blankenship, President. “This move is the culmination of years of research and development as we listened to what our customers wanted and delivered a cost-effective supplement with StemStrength™.”

AngioSoma is excited to continue to innovate for its customers across the spectrum of health-related products. This new enhanced formula of StemStrength™ allows the company to reach a wider audience as it prepares consumer sales channels for this product and others coming down the development pipeline.

Our products can be found at:


AngioSoma, Inc. (, a Nevada corporation based in Houston, Texas, is dedicated to improving the mental and physical wellbeing of men and women. To accomplish that purpose, we are launching a line of supplements under our SomaCeuticals™ common identity. Our supplements cover three industry segments: nutraceuticals, cosmeceuticals, and pharmaceuticals.


Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements.